An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain Giovambattista.

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.

The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.

A Network Meta-Analysis of the Efficacy of Opioid Analgesics for the Management of Breakthrough Cancer Pain Episodes Giovambattista Zeppetella, FRCP,

One-Year rTMS Treatment for Refractory Trigeminal Neuralgia

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Jane Gibbins, MD, MRCP, Colette M

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief Giovambattista Zeppetella, FRCP Journal.

Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment Katherine Webber, MBBS, MSc, PhD, Andrew.

Managing the Symptoms of Neuropathic Pain: An Exploration of Patients' Experiences S. José Closs, BSc, RGN, MPhil, PhD, Vicki Staples, BSc, MSc, Innes.

A comparison of five pain assessment scales for nursing home residents with varying degrees of cognitive impairment S.José Closs, BSc, MPhil, PhD, RGN,

Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and Sleep Mugdha Gore,

Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN

Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter,

Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine Rainer Sabatowski, MD, Stefan.

Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate.

A Network Meta-Analysis of the Efficacy of Opioid Analgesics for the Management of Breakthrough Cancer Pain Episodes Giovambattista Zeppetella, FRCP,

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

Use of Ketamine for Ischemic Pain in End-Stage Renal Failure

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.

Delirium in Terminal Cancer

Isaac M. Bromberg, MD Journal of Pain and Symptom Management

Advances in Rheumatology

One-Year rTMS Treatment for Refractory Trigeminal Neuralgia

Transdermal Fentanyl for Chronic Pain in AIDS

A Systematic Review Examining the Literature on Attitudes of Patients with Advanced Cancer Toward Research Anne M.H. Todd, BA (Hons), Barry J.A. Laird,

A Trial of Intravenous Lidocaine on the Pain and Allodynia of Postherpetic Neuralgia Andrew P Baranowski, BSc (Hons), MB BS, MD, FRCA, James De Courcey,

Xerostomia in Patients with Advanced Cancer

Long-Term Analgesic Effects of Transcranial Direct Current Stimulation of the Motor Cortex on Phantom Limb and Stump Pain: A Case Report Nadia Bolognini,

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Development of a Cancer Pain Prognostic Scale

Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state P.S.

The Carer Support Needs Assessment Tool (CSNAT) for Use in Palliative and End-of- life Care at Home: A Validation Study Gail Ewing, BSc, PhD, RGN, Caroline.

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

English Proficiency, Symptoms, and Quality of Life in Vietnamese- and Chinese- American Breast Cancer Survivors Jenny K. Yi, PhD, Michael D. Swartz, PhD,

Symptom Prevalence and Management of Cancer Patients in Lebanon

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP) Julie E. Gilbert, MSc, PhD,

The Influence of Low Salivary Flow Rates on the Absorption of a Sublingual Fentanyl Citrate Formulation for Breakthrough Cancer Pain Andrew Davies, FRCP,

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD

Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine.

Montarat Chinda, MD, Darin Jaturapatporn, MD, Albert J

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

The Assessment of Cancer Pain in North India

The Impact of Symptoms, Coping Capacity, and Social Support on Quality of Life Experience Over Time in Patients with Lung Cancer Ingela Henoch, RN, PhD,

U.S. Hospice Benefits Journal of Pain and Symptom Management

Barriers to Cancer Pain Relief

Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS) G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,

The Impact of Delirium on the Circadian Distribution of Breakthrough Analgesia in Advanced Cancer Patients Bruno Gagnon, MD, Peter G. Lawlor, MB, Isabelle.

Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain Richard Payne, MD, Paul Coluzzi, MD, Lowell Hart, MD, Mary Simmonds,

Carmen R. Green, MD, Laura Montague, BS, Tamera A. Hart-Johnson, MS

Dylan G. Harris, MBBCh (Hons), MRCP, DipPallMed, Simon I. R

Propensity Scores: A Practical Method for Assessing Treatment Effects in Pain and Symptom Management Research Melissa M. Garrido, PhD Journal of Pain.

The Asia Pacific Hospice Palliative Care Network

A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients Sharon M. Watanabe, MD, Cheryl.

Physical Function in Patients with Cancer

Effects of Prophylactic Subcutaneous Fentanyl on Exercise-Induced Breakthrough Dyspnea in Cancer Patients: A Preliminary Double-Blind, Randomized, Controlled.

Novel Use of Amantadine: To Treat Hiccups

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP) Julie E. Gilbert, MSc, PhD,

Impact of Dyspnea, Pain, and Fatigue on Daily Life Activities in Ambulatory Patients with Advanced Lung Cancer Keiko Tanaka, MD, Tatsuo Akechi, MD, PhD,

Katherine Webber, MBBS, Andrew N

Fatigue in Patients with Cancers of the Breast or Prostate Undergoing Radical Radiotherapy Patrick Stone, MA, MD, MRCP, Michael Richards, MA, MD, MRCP,

Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals Jane Hopkinson, PhD, RGN, Jessica.

The bioavailability of morphine applied topically to cutaneous ulcers

A Multicenter Study Comparing Two Numerical Versions of the Edmonton Symptom Assessment System in Palliative Care Patients Sharon M. Watanabe, MD, Cheryl.

Use of Pregabalin in the Management of Chronic Uremic Pruritus

Papiya B. Russell, BSc, MBChB, MRCP, Sarah C

Presentation transcript:

An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain Giovambattista Zeppetella, BSc (Hons), MRCGP Journal of Pain and Symptom Management Volume 20, Issue 4, Pages 253-258 (October 2000) DOI: 10.1016/S0885-3924(00)00180-9

Fig. 1 Mean percentage change in visual analogue scale scores for patients reporting benefit from INFC Journal of Pain and Symptom Management 2000 20, 253-258DOI: (10.1016/S0885-3924(00)00180-9)

Fig. 2 Mean percentage change in visual analogue scale scores for patients reporting no benefit from INFC Journal of Pain and Symptom Management 2000 20, 253-258DOI: (10.1016/S0885-3924(00)00180-9)